Clinical Trial Update: Bevacizumab Therapy Untreated Unresectable Liver Metastases From Colorectal Cancer [Phase 2]

View source ↗

Summary

Bevacizumab is being investigated in a Phase 2 trial for untreated unresectable liver metastases from colorectal cancer; the document notes the trial status as …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Liaoning Cancer Hospital & Institute | Conditions: Liver Metastases, Colorectal Cancer | Phase 2 | Status: UNKNOWN